HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: HSK7653 10 mg Q2W;   Drug: HSK7653 25 mg Q2W;   Drug: Linagliptin 5 mg QD Sponsor:   Sichuan Haisco Pharmaceutical Group Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - September 25, 2020 Category: Research Source Type: clinical trials